Robin L Jones Selected Research

Trabectedin

3/2022	Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients.
1/2022	A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
7/2021	Pharmacotherapy for liposarcoma: current and emerging synthetic treatments.
1/2021	Cardiac safety of trabectedin monotherapy or in combination with pegylated liposomal doxorubicin in patients with sarcomas and ovarian cancer.
12/2019	Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin.
12/2018	Preserving quality of life as a key treatment goal in advanced soft tissue sarcomas.
1/2017	Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma.
1/2017	Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial.
4/2016	Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options.
3/2016	Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robin L Jones Research Topics

Disease

102	Sarcoma (Soft Tissue Sarcoma) 03/2022 - 07/2007
85	Neoplasms (Cancer) 03/2022 - 07/2004
23	Liposarcoma 01/2022 - 12/2005
21	Leiomyosarcoma 01/2022 - 12/2011
21	Breast Neoplasms (Breast Cancer) 10/2019 - 07/2004
13	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 04/2022 - 05/2013
13	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2007
12	Disease Progression 01/2022 - 03/2016
12	Synovial Sarcoma (Synovioma) 01/2022 - 05/2011
11	Cardiotoxicity 01/2021 - 07/2004
9	Testicular Neoplasms (Testicular Cancer) 01/2022 - 01/2011
8	Hemangiosarcoma (Angiosarcoma) 02/2022 - 10/2012
7	Myxoid Liposarcoma 01/2022 - 12/2005
6	Fatigue 01/2022 - 01/2018
5	Anemia 01/2022 - 01/2017
5	Nausea 01/2022 - 07/2016
5	Aggressive Fibromatosis (Desmoid) 12/2020 - 11/2009
5	Ewing Sarcoma (Sarcoma, Ewing) 05/2015 - 05/2010
4	Clear Cell Sarcoma 02/2022 - 09/2011
4	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 05/2015
4	Carcinogenesis 01/2020 - 01/2007
3	Vomiting 01/2022 - 07/2016
3	Diarrhea 01/2022 - 10/2020
3	Carcinoma (Carcinomatosis) 12/2019 - 09/2007
3	Neutropenia 01/2018 - 07/2016
3	Febrile Neutropenia 01/2017 - 07/2016
2	Leiomyoma (Uterine Fibroids) 06/2022 - 11/2016
2	Melanoma (Melanoma, Malignant) 01/2022 - 05/2018
2	Rhabdomyosarcoma 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2022 - 01/2020
2	Hypoxia (Hypoxemia) 03/2021 - 01/2017
2	Hemorrhage 01/2021 - 10/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2019
2	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2017
2	Myocarditis (Carditis) 01/2020 - 11/2006
2	Sepsis (Septicemia) 01/2020 - 01/2017
2	Leukopenia 01/2018 - 01/2017
2	Chondrosarcoma 08/2017 - 01/2012
2	Thrombocytopenia (Thrombopenia) 01/2017 - 01/2017
2	Dermatofibrosarcoma 12/2016 - 12/2015
2	Soft Tissue Neoplasms 02/2016 - 01/2016
2	Adenosarcoma of the uterus 02/2014 - 06/2013

Drug/Important Bio-Agent (IBA)

30	AnthracyclinesIBA 01/2021 - 07/2004
21	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021 - 05/2011
15	TrabectedinIBA 03/2022 - 07/2007
11	Pharmaceutical PreparationsIBA 01/2021 - 09/2009
10	pazopanib FDA Link 01/2022 - 01/2013
10	AntigensIBA 01/2022 - 01/2011
9	Tyrosine Kinase InhibitorsIBA 04/2022 - 01/2016
9	Biomarkers (Surrogate Marker)IBA 02/2022 - 07/2008
9	olaratumabIBA 10/2021 - 07/2016
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2006
7	Gemcitabine FDA Link 12/2020 - 01/2015
7	Ifosfamide FDA LinkGeneric 01/2018 - 05/2011
6	Biological ProductsIBA 01/2022 - 05/2010
6	Dacarbazine (DIC)FDA LinkGeneric 01/2022 - 03/2016
6	Phosphotransferases (Kinase)IBA 01/2021 - 02/2013
6	Monoclonal AntibodiesIBA 01/2019 - 07/2006
5	Imatinib Mesylate (Gleevec)FDA Link 01/2022 - 01/2013
5	eribulin FDA Link 01/2022 - 01/2017
5	VaccinesIBA 12/2021 - 09/2012
5	ripretinibIBA 12/2021 - 01/2020
5	regorafenibIBA 10/2021 - 05/2015
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2021 - 01/2017
4	avapritinibIBA 10/2021 - 08/2020
4	liposomal doxorubicin (Doxil)FDA Link 01/2021 - 09/2004
4	ParaffinIBA 01/2021 - 07/2008
4	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021 - 11/2006
3	Immune Checkpoint InhibitorsIBA 02/2022 - 05/2018
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 09/2017
3	Formaldehyde (Formol)FDA Link 01/2021 - 07/2008
3	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2015
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 06/2019
2	tazemetostatIBA 01/2022 - 11/2020
2	selinexorIBA 01/2022 - 08/2021
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 01/2012
2	Neutralizing AntibodiesIBA 12/2021 - 12/2021
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 01/2014
2	Alkylating AgentsIBA 01/2021 - 02/2015
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 11/2019
2	AlkaloidsIBA 01/2020 - 02/2014
2	ProdrugsIBA 05/2019 - 01/2017
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2019 - 01/2014
2	Angiogenesis InhibitorsIBA 08/2017 - 01/2013
2	S100 Proteins (S 100 Protein)IBA 03/2017 - 03/2016
2	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 12/2008
2	isophosphamide mustard (IPAM)IBA 01/2017 - 11/2016
2	Insulin (Novolin)FDA Link 02/2015 - 05/2010
2	PM 00104IBA 08/2014 - 02/2014
2	Insulin-Like PeptidesIBA 01/2011 - 05/2010
2	Estrogen ReceptorsIBA 08/2010 - 06/2008

Therapy/Procedure

64	Therapeutics 01/2022 - 11/2006
57	Drug Therapy (Chemotherapy) 01/2022 - 02/2003
16	Neoadjuvant Therapy 01/2022 - 10/2006
10	Immunotherapy 02/2022 - 01/2011
7	Radiotherapy 11/2020 - 11/2006
4	Adjuvant Chemotherapy 01/2022 - 06/2008
2	Precision Medicine 03/2021 - 01/2021
2	Combination Drug Therapy (Combination Chemotherapy) 12/2020 - 01/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2018 - 05/2018